Skip to content
NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · LARGE CAP

Zimmer Biomet Holdings, Inc. ZBH

19 fiscal years on record · USD · FY2025 reported · SEC filings only
$8.2B
▲ 7.2% YoY
$705.1M
▼ 22.0% YoY
$1.5B
▲ 13.7% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Zimmer Biomet designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities and trauma products, craniomaxillofacial and thoracic products, bone cement, surgical products, and a suite of integrated digital and robotic technologies. It allocates resources through three regional operating segments, comprised of the Americas; Europe, Middle East and Africa; and Asia Pacific. Zimmer Biomet Holdings was incorporated in Delaware in 2001, tracing its history to 1927 when Zimmer Manufacturing Company, its predecessor, was founded in Warsaw, Indiana.

Written from the business description in ZIMMER BIOMET HOLDINGS, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 20 February 2026. Every sentence was checked against that document before publication.

Growth

USD 8.2B
Revenue, FY2025 · full 19-year series below
Revenue $B Net income $B
FY2025 · Revenue 8.2 · Net income 0.7
3B6B
2007201020132016201920222025
Compound annual growth
+5.9%
+6.1%
+3.2%
+4.6%
+45.0%
+17.0%
+1.1%
+47.8%
+16.5%
+1.2%
+0.0%
+0.0%
+0.9%
+27.4%
+27.8%
+8.2%
+2.0%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +6.1% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

9 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 13.3% · Net 8.6%
10%20%-2%-4%
200720162025
ROE
FY2025 · ROE 5.6%
5%10%15%-1%-2%-3%
200720162025
Three returns, three denominators.

Each USD of equity produced 6 cents of profit this year.

Cash & shareholders

USD 677.3M
returned in FY2025 · dividends + net buybacks
Free cash flow $B
FY2025 · FCF 1.5
1B2B
200720162025
Net buybacks $B Dividends $B
FY2025 · Dividends 0.2 · Net buybacks 0.5
0.5B1.0BDividendsNet buybacks
2007201020132016201920222025

USD 190.3M in dividends and USD 487.0M in buybacks — 96% of the year's profit went back to shareholders.

Total assetsUSD 23.1B
EquityUSD 12.7B
CashUSD 591.9M
Gross debtUSD 7.5B
Net debtUSD 6.9B
Current ratio1.98×

Net debt stands at 55% of equity.

The 19-year record

19 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
ZBH, 19-year financial record
Metric 2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue $B8.27.77.46.96.86.18.07.97.87.76.04.74.64.54.54.24.14.13.9
Operating income $B1.11.31.30.70.90.11.10.00.80.80.51.01.11.01.00.91.01.11.1
EBITDA $B2.22.32.21.61.81.02.11.11.91.91.21.41.41.41.41.31.41.41.4
Income tax $B0.10.10.00.10.1−0.1−0.20.1−1.30.10.00.20.20.20.20.30.30.30.4
Net income $B0.70.91.00.20.4−0.11.1−0.41.80.30.10.70.80.80.80.60.70.80.8
Free cash flow $B1.51.31.31.21.31.01.41.61.41.40.70.90.91.01.11.11.00.80.9
EPS, diluted $3.554.434.881.101.91−0.675.47−1.868.901.510.774.204.544.294.032.973.323.723.26
Dividend / sh $0.960.960.960.960.960.960.960.960.960.960.880.880.800.540.18◌◌◌◌
Payout %2722208750−14317−511162107201713—————
ROE %5.67.28.41.93.2−1.19.6−3.316.93.11.811.212.813.313.510.512.715.314.2

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 82 reconciliationsAUDITED

Reconciled in 19 of the 19 fiscal years we could check. Two checks were skipped: the balance sheet is not tagged before 2008.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityOrthopedic, Prosthetic & Surgical Appliances & Supplies
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2007

Share this section

Download image